Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis

Thorax

Volumn 59, Issue 6, 2004, Pages 536-537

  Elliott, C G ^a,c   Palevsky, H I ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN; ANTIHYPERTENSIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DOSE CALCULATION; FEMALE; HEART CATHETERIZATION; HUMAN; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SAINT JUDE HEART VALVE PROSTHESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; HEART VALVE REPLACEMENT; MIDDLE AGED; POSTOPERATIVE COMPLICATION;

ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; MITRAL VALVE STENOSIS; POSTOPERATIVE COMPLICATIONS;

EID: 2942672803     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2003.008193     Document Type: Article

References (10)

1. Higenbottam T, Wheeldon D, Wells F, et al. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984;1:1046-7.
2. Dalen JE, Matloff JM, Evans GL, et al. Early reduction of pulmonary vascular resistance after mitral-valve replacement. N Engl J Med 1967;277:387-94.
3. Braunwald E, Braunwald NS, Ross J, et al. Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension. N Engl J Med 1965;273:509-14.
4. Wood P. The vasoconstrictive factor in pulmonary hypertension. In: Adams WR, Veith I, eds. Pulmonary circulation: an international symposium. New York: Grune, 1959:294-301.
5. Likoff W. Change in pulmonary vascular resistance after relief of mitral obstruction. In: Adams WR, Veith I, eds. Pulmonary circulation: an international symposium. New York: Grune, 1959:302-10.
6. Tandon HD, Kasturi J. Pulmonary vascular changes associated with isolated mitral stenosis in India. Br Heart J 1975;37:26-36.
7. Langleben D, Lamourex E, Marcotte F, et al. Mitral stenosis obscuring the diagnosis of plexigenic pulmonary arteriopathy and familial pulmonary hypertension. Thorax 2000;55:247-8.
8. Cheng TO. Differentiation between mitral stenosis and coexisting primary pulmonary hypertension. Thorax 2000;55:807.
9. Langleben D, Schlesinger R. Differentiation between mitral stenosis and coexisting primary pulmonary hypertension: authors' reply. Thorax 2000;55:807.
10. McLaughlin VV, Genthner DE, Panella MM, et al. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338:273-7.